Please login to the form below

Not currently logged in
Email:
Password:

HIV vaccine

This page shows the latest HIV vaccine news and features for those working in and with pharma, biotech and healthcare.

Janssen’s quest to prevent diseases taking hold

Janssen’s quest to prevent diseases taking hold

Janssen’s acquisition of Crucell in 2011 brought it a suite of promising platforms covering HIV, a universal flu vaccine, respiratory syncytial virus (RSV), which is an infection of the lungs ... This potent test bed has helped with development of its

Latest news

  • GSK’s pipeline cull claims sirukumab, and possibly rare disease unit GSK’s pipeline cull claims sirukumab, and possibly rare disease unit

    The company has spread its R&D spend too thinly in the past, and needs to focus on a smaller number of therapeutic categories - HIV and respiratory plus oncology and ... Over the next three years the critical new products for GSK will be its closed

  • Efficacy trials get underway for HIV vaccine in South Africa Efficacy trials get underway for HIV vaccine in South Africa

    Efficacy trials get underway for HIV vaccine in South Africa. Study hopes to provide partial immunity against the virus. ... Researchers are testing an HIV vaccine in efficacy trials for the first time in seven years in the hope that the candidate will

  • Bionor gears up for 'kick and kill' HIV data Bionor gears up for 'kick and kill' HIV data

    Norwegian biotech Bionor is just weeks away from completing a clinical trial to gauge the effectiveness of its therapeutic vaccine for HIV. ... an opportunity to see whether the 'kick and kill' theory of HIV therapy may achieve a cure.

  • HIV vaccine from J&J starts human trials HIV vaccine from J&J starts human trials

    HIV vaccine from J&J starts human trials. Vaccine provided complete protection in primates for similar infection . ... Scarcity of funding is also threatening a Russian HIV vaccine candidate called CombiHIVvac, which is heading for phase II testing.

  • Russian HIV vaccine heading for phase II trials Russian HIV vaccine heading for phase II trials

    Russian HIV vaccine heading for phase II trials. But trials could be affected by lack of funding. ... A candidate HIV vaccine developed in Russia is on the brink of starting phase II trials but could be stymied by a lack of funding, according to the

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest appointments

  • Aelix Therapeutics appoints Dr Thomas Hecht Aelix Therapeutics appoints Dr Thomas Hecht

    its HIV vaccine. ... After decades of work to develop a HIV vaccine, I hope to contribute with my experience in building a strong player that I believe has good chances to be amongst the

  • Sanofi appoints NIH’s Gary Nabel as chief scientific officer Sanofi appoints NIH’s Gary Nabel as chief scientific officer

    Sanofi appoints NIH’ s Gary Nabel as chief scientific officer. He previously headed vaccine research centre of the US National Institute of Allergy and Infectious Diseases. ... During this period, he provided overall direction of the VRC, including the

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics